nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Infection—Etoposide—muscle cancer	0.00103	0.00103	CcSEcCtD
Rivastigmine—Ataxia—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Rivastigmine—Asthenia—Dactinomycin—muscle cancer	0.00103	0.00103	CcSEcCtD
Rivastigmine—Dysuria—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Rivastigmine—Dehydration—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Rivastigmine—Thrombocytopenia—Etoposide—muscle cancer	0.00102	0.00102	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00102	0.00102	CcSEcCtD
Rivastigmine—Tachycardia—Etoposide—muscle cancer	0.00102	0.00102	CcSEcCtD
Rivastigmine—Abdominal pain—Vincristine—muscle cancer	0.00102	0.00102	CcSEcCtD
Rivastigmine—Body temperature increased—Vincristine—muscle cancer	0.00102	0.00102	CcSEcCtD
Rivastigmine—Liver function test abnormal—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Rivastigmine—Skin disorder—Etoposide—muscle cancer	0.00101	0.00101	CcSEcCtD
Rivastigmine—Erectile dysfunction—Methotrexate—muscle cancer	0.00101	0.00101	CcSEcCtD
Rivastigmine—Dry skin—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Rivastigmine—Hyperhidrosis—Etoposide—muscle cancer	0.00101	0.00101	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.001	0.001	CcSEcCtD
Rivastigmine—Abdominal pain upper—Doxorubicin—muscle cancer	0.001	0.001	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Methotrexate—muscle cancer	0.001	0.001	CcSEcCtD
Rivastigmine—Hypokalaemia—Doxorubicin—muscle cancer	0.001	0.001	CcSEcCtD
Rivastigmine—Breast disorder—Doxorubicin—muscle cancer	0.000993	0.000993	CcSEcCtD
Rivastigmine—Anorexia—Etoposide—muscle cancer	0.000992	0.000992	CcSEcCtD
Rivastigmine—Diarrhoea—Dactinomycin—muscle cancer	0.000984	0.000984	CcSEcCtD
Rivastigmine—Pneumonia—Methotrexate—muscle cancer	0.000983	0.000983	CcSEcCtD
Rivastigmine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000982	0.000982	CcSEcCtD
Rivastigmine—Infestation NOS—Methotrexate—muscle cancer	0.000978	0.000978	CcSEcCtD
Rivastigmine—Infestation—Methotrexate—muscle cancer	0.000978	0.000978	CcSEcCtD
Rivastigmine—Drowsiness—Methotrexate—muscle cancer	0.000978	0.000978	CcSEcCtD
Rivastigmine—Depression—Methotrexate—muscle cancer	0.000975	0.000975	CcSEcCtD
Rivastigmine—Hypotension—Etoposide—muscle cancer	0.000973	0.000973	CcSEcCtD
Rivastigmine—Gastritis—Doxorubicin—muscle cancer	0.000972	0.000972	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000969	0.000969	CcSEcCtD
Rivastigmine—Muscular weakness—Doxorubicin—muscle cancer	0.000969	0.000969	CcSEcCtD
Rivastigmine—Renal failure—Methotrexate—muscle cancer	0.000961	0.000961	CcSEcCtD
Rivastigmine—Conjunctivitis—Methotrexate—muscle cancer	0.00095	0.00095	CcSEcCtD
Rivastigmine—Dysphagia—Doxorubicin—muscle cancer	0.000949	0.000949	CcSEcCtD
Rivastigmine—Hypersensitivity—Vincristine—muscle cancer	0.000947	0.000947	CcSEcCtD
Rivastigmine—Sweating—Methotrexate—muscle cancer	0.000937	0.000937	CcSEcCtD
Rivastigmine—Paraesthesia—Etoposide—muscle cancer	0.000935	0.000935	CcSEcCtD
Rivastigmine—Haematuria—Methotrexate—muscle cancer	0.000932	0.000932	CcSEcCtD
Rivastigmine—Pancreatitis—Doxorubicin—muscle cancer	0.000931	0.000931	CcSEcCtD
Rivastigmine—Dyspnoea—Etoposide—muscle cancer	0.000928	0.000928	CcSEcCtD
Rivastigmine—Somnolence—Etoposide—muscle cancer	0.000925	0.000925	CcSEcCtD
Rivastigmine—Angina pectoris—Doxorubicin—muscle cancer	0.000925	0.000925	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000925	0.000925	CcSEcCtD
Rivastigmine—Epistaxis—Methotrexate—muscle cancer	0.000922	0.000922	CcSEcCtD
Rivastigmine—Asthenia—Vincristine—muscle cancer	0.000922	0.000922	CcSEcCtD
Rivastigmine—Vomiting—Dactinomycin—muscle cancer	0.000914	0.000914	CcSEcCtD
Rivastigmine—Bronchitis—Doxorubicin—muscle cancer	0.000913	0.000913	CcSEcCtD
Rivastigmine—Rash—Dactinomycin—muscle cancer	0.000907	0.000907	CcSEcCtD
Rivastigmine—Decreased appetite—Etoposide—muscle cancer	0.000905	0.000905	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000899	0.000899	CcSEcCtD
Rivastigmine—Fatigue—Etoposide—muscle cancer	0.000897	0.000897	CcSEcCtD
Rivastigmine—Pain—Etoposide—muscle cancer	0.00089	0.00089	CcSEcCtD
Rivastigmine—Constipation—Etoposide—muscle cancer	0.00089	0.00089	CcSEcCtD
Rivastigmine—Dysuria—Doxorubicin—muscle cancer	0.000888	0.000888	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000882	0.000882	CcSEcCtD
Rivastigmine—Haemoglobin—Methotrexate—muscle cancer	0.000882	0.000882	CcSEcCtD
Rivastigmine—Diarrhoea—Vincristine—muscle cancer	0.000879	0.000879	CcSEcCtD
Rivastigmine—Haemorrhage—Methotrexate—muscle cancer	0.000878	0.000878	CcSEcCtD
Rivastigmine—Hepatitis—Methotrexate—muscle cancer	0.000878	0.000878	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—muscle cancer	0.000877	0.000877	CcSEcCtD
Rivastigmine—Pharyngitis—Methotrexate—muscle cancer	0.000871	0.000871	CcSEcCtD
Rivastigmine—Urinary tract disorder—Methotrexate—muscle cancer	0.000867	0.000867	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000867	0.000867	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—muscle cancer	0.000864	0.000864	CcSEcCtD
Rivastigmine—Urethral disorder—Methotrexate—muscle cancer	0.00086	0.00086	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—muscle cancer	0.000859	0.000859	CcSEcCtD
Rivastigmine—Feeling abnormal—Etoposide—muscle cancer	0.000858	0.000858	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000856	0.000856	CcSEcCtD
Rivastigmine—Nausea—Dactinomycin—muscle cancer	0.000854	0.000854	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—muscle cancer	0.000851	0.000851	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Etoposide—muscle cancer	0.000851	0.000851	CcSEcCtD
Rivastigmine—Dizziness—Vincristine—muscle cancer	0.00085	0.00085	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—muscle cancer	0.000847	0.000847	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—muscle cancer	0.000847	0.000847	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—muscle cancer	0.000847	0.000847	CcSEcCtD
Rivastigmine—Visual impairment—Methotrexate—muscle cancer	0.000846	0.000846	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000839	0.000839	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—muscle cancer	0.000832	0.000832	CcSEcCtD
Rivastigmine—Erythema multiforme—Methotrexate—muscle cancer	0.00083	0.00083	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00083	0.00083	CcSEcCtD
Rivastigmine—Urticaria—Etoposide—muscle cancer	0.000827	0.000827	CcSEcCtD
Rivastigmine—Abdominal pain—Etoposide—muscle cancer	0.000823	0.000823	CcSEcCtD
Rivastigmine—Body temperature increased—Etoposide—muscle cancer	0.000823	0.000823	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—muscle cancer	0.000823	0.000823	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—muscle cancer	0.000823	0.000823	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—muscle cancer	0.00082	0.00082	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—muscle cancer	0.000818	0.000818	CcSEcCtD
Rivastigmine—Vomiting—Vincristine—muscle cancer	0.000817	0.000817	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—muscle cancer	0.000815	0.000815	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—muscle cancer	0.000812	0.000812	CcSEcCtD
Rivastigmine—Rash—Vincristine—muscle cancer	0.00081	0.00081	CcSEcCtD
Rivastigmine—Dermatitis—Vincristine—muscle cancer	0.000809	0.000809	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—muscle cancer	0.000807	0.000807	CcSEcCtD
Rivastigmine—Headache—Vincristine—muscle cancer	0.000805	0.000805	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000801	0.000801	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—muscle cancer	0.000798	0.000798	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—muscle cancer	0.000796	0.000796	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—muscle cancer	0.000794	0.000794	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—muscle cancer	0.000791	0.000791	CcSEcCtD
Rivastigmine—Chills—Methotrexate—muscle cancer	0.000787	0.000787	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—muscle cancer	0.000776	0.000776	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—muscle cancer	0.000774	0.000774	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—muscle cancer	0.000769	0.000769	CcSEcCtD
Rivastigmine—Hypersensitivity—Etoposide—muscle cancer	0.000767	0.000767	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—muscle cancer	0.000764	0.000764	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—muscle cancer	0.000764	0.000764	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—muscle cancer	0.000764	0.000764	CcSEcCtD
Rivastigmine—Nausea—Vincristine—muscle cancer	0.000763	0.000763	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—muscle cancer	0.000762	0.000762	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—muscle cancer	0.00076	0.00076	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—muscle cancer	0.00076	0.00076	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000756	0.000756	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—muscle cancer	0.000754	0.000754	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—muscle cancer	0.00075	0.00075	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—muscle cancer	0.000749	0.000749	CcSEcCtD
Rivastigmine—Dysgeusia—Methotrexate—muscle cancer	0.000748	0.000748	CcSEcCtD
Rivastigmine—Asthenia—Etoposide—muscle cancer	0.000747	0.000747	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000747	0.000747	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—muscle cancer	0.000745	0.000745	CcSEcCtD
Rivastigmine—Back pain—Methotrexate—muscle cancer	0.000739	0.000739	CcSEcCtD
Rivastigmine—Pruritus—Etoposide—muscle cancer	0.000736	0.000736	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—muscle cancer	0.000732	0.000732	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—muscle cancer	0.00072	0.00072	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—muscle cancer	0.000719	0.000719	CcSEcCtD
Rivastigmine—Diarrhoea—Etoposide—muscle cancer	0.000712	0.000712	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—muscle cancer	0.00071	0.00071	CcSEcCtD
Rivastigmine—Ill-defined disorder—Methotrexate—muscle cancer	0.000709	0.000709	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—muscle cancer	0.000709	0.000709	CcSEcCtD
Rivastigmine—Anaemia—Methotrexate—muscle cancer	0.000706	0.000706	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—muscle cancer	0.000705	0.000705	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—muscle cancer	0.000705	0.000705	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—muscle cancer	0.000689	0.000689	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—muscle cancer	0.000689	0.000689	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—muscle cancer	0.000688	0.000688	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—muscle cancer	0.000686	0.000686	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000685	0.000685	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—muscle cancer	0.000682	0.000682	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—muscle cancer	0.000679	0.000679	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—muscle cancer	0.000672	0.000672	CcSEcCtD
Rivastigmine—Cough—Methotrexate—muscle cancer	0.000667	0.000667	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—muscle cancer	0.000666	0.000666	CcSEcCtD
Rivastigmine—Convulsion—Methotrexate—muscle cancer	0.000662	0.000662	CcSEcCtD
Rivastigmine—Vomiting—Etoposide—muscle cancer	0.000662	0.000662	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—muscle cancer	0.000662	0.000662	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—muscle cancer	0.000662	0.000662	CcSEcCtD
Rivastigmine—Rash—Etoposide—muscle cancer	0.000656	0.000656	CcSEcCtD
Rivastigmine—Dermatitis—Etoposide—muscle cancer	0.000656	0.000656	CcSEcCtD
Rivastigmine—Headache—Etoposide—muscle cancer	0.000652	0.000652	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—muscle cancer	0.000652	0.000652	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—muscle cancer	0.00065	0.00065	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—muscle cancer	0.00065	0.00065	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—muscle cancer	0.00065	0.00065	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—muscle cancer	0.000649	0.000649	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—muscle cancer	0.000648	0.000648	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000646	0.000646	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—muscle cancer	0.000643	0.000643	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—muscle cancer	0.000643	0.000643	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—muscle cancer	0.00064	0.00064	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—muscle cancer	0.000636	0.000636	CcSEcCtD
Rivastigmine—Confusional state—Methotrexate—muscle cancer	0.000629	0.000629	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—muscle cancer	0.000623	0.000623	CcSEcCtD
Rivastigmine—Infection—Methotrexate—muscle cancer	0.000619	0.000619	CcSEcCtD
Rivastigmine—Nausea—Etoposide—muscle cancer	0.000618	0.000618	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000614	0.000614	CcSEcCtD
Rivastigmine—Nervous system disorder—Methotrexate—muscle cancer	0.000611	0.000611	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—muscle cancer	0.000611	0.000611	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—muscle cancer	0.00061	0.00061	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—muscle cancer	0.000608	0.000608	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—muscle cancer	0.000606	0.000606	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—muscle cancer	0.000603	0.000603	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—muscle cancer	0.000597	0.000597	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—muscle cancer	0.000594	0.000594	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—muscle cancer	0.000594	0.000594	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—muscle cancer	0.000593	0.000593	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—muscle cancer	0.000585	0.000585	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—muscle cancer	0.000583	0.000583	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—muscle cancer	0.000581	0.000581	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—muscle cancer	0.000577	0.000577	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—muscle cancer	0.000573	0.000573	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—muscle cancer	0.000571	0.000571	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000568	0.000568	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—muscle cancer	0.000564	0.000564	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—muscle cancer	0.000563	0.000563	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—muscle cancer	0.000563	0.000563	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—muscle cancer	0.000563	0.000563	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—muscle cancer	0.000561	0.000561	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—muscle cancer	0.00056	0.00056	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000559	0.000559	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—muscle cancer	0.000556	0.000556	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—muscle cancer	0.000556	0.000556	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—muscle cancer	0.000554	0.000554	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—muscle cancer	0.000551	0.000551	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—muscle cancer	0.000549	0.000549	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—muscle cancer	0.000544	0.000544	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—muscle cancer	0.000542	0.000542	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—muscle cancer	0.00054	0.00054	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000538	0.000538	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—muscle cancer	0.000538	0.000538	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—muscle cancer	0.000536	0.000536	CcSEcCtD
Rivastigmine—Pain—Methotrexate—muscle cancer	0.000533	0.000533	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—muscle cancer	0.000531	0.000531	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—muscle cancer	0.000529	0.000529	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000529	0.000529	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—muscle cancer	0.000527	0.000527	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—muscle cancer	0.000524	0.000524	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000522	0.000522	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—muscle cancer	0.000515	0.000515	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—muscle cancer	0.000514	0.000514	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00051	0.00051	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—muscle cancer	0.000505	0.000505	CcSEcCtD
Rivastigmine—Urticaria—Methotrexate—muscle cancer	0.000495	0.000495	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—muscle cancer	0.000493	0.000493	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—muscle cancer	0.000493	0.000493	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000492	0.000492	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—muscle cancer	0.000488	0.000488	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—muscle cancer	0.000485	0.000485	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—muscle cancer	0.000481	0.000481	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—muscle cancer	0.00048	0.00048	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—muscle cancer	0.000475	0.000475	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—muscle cancer	0.000469	0.000469	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000466	0.000466	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—muscle cancer	0.000465	0.000465	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—muscle cancer	0.000462	0.000462	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—muscle cancer	0.000462	0.000462	CcSEcCtD
Rivastigmine—Hypersensitivity—Methotrexate—muscle cancer	0.000459	0.000459	CcSEcCtD
Rivastigmine—Asthenia—Methotrexate—muscle cancer	0.000447	0.000447	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—muscle cancer	0.000445	0.000445	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000441	0.000441	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—muscle cancer	0.000441	0.000441	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—muscle cancer	0.000429	0.000429	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—muscle cancer	0.000427	0.000427	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—muscle cancer	0.000427	0.000427	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—muscle cancer	0.000427	0.000427	CcSEcCtD
Rivastigmine—Dizziness—Methotrexate—muscle cancer	0.000412	0.000412	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—muscle cancer	0.000398	0.000398	CcSEcCtD
Rivastigmine—Vomiting—Methotrexate—muscle cancer	0.000396	0.000396	CcSEcCtD
Rivastigmine—Rash—Methotrexate—muscle cancer	0.000393	0.000393	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—muscle cancer	0.000393	0.000393	CcSEcCtD
Rivastigmine—Headache—Methotrexate—muscle cancer	0.000391	0.000391	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—muscle cancer	0.000387	0.000387	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—muscle cancer	0.000382	0.000382	CcSEcCtD
Rivastigmine—Nausea—Methotrexate—muscle cancer	0.00037	0.00037	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—muscle cancer	0.000369	0.000369	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—muscle cancer	0.000357	0.000357	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—muscle cancer	0.000343	0.000343	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—muscle cancer	0.00034	0.00034	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—muscle cancer	0.00034	0.00034	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—muscle cancer	0.000338	0.000338	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—muscle cancer	0.000321	0.000321	CcSEcCtD
